Capacity Building Webinar: TCS Gateway into IVD Market in China
Webinar | Tuesday, January 21, 2025, 7:00 PM EST / Wednesday, January 22, 2025, 8:00 AM China
RegisterIn 2023, the Chinese IVD market reached a value of USD 16.6 billion, showing steady growth after adjusting for the impact of COVID-19. Imported products made up 50% of total sales, an increase from 40% in 2022. The demand for clinical immunology saw a strong annual growth of 15%, highlighting its expansion. Notably, 65% of immunology products were imported, underscoring significant opportunities for international players, particularly in the high-end market segment.
Brought to you by the Canadian Trade Commissioner Service (TCS) in Shanghai with co-organizer China Association of In Vitro Diagnostics, this capacity-building webinar offers in-market expert insights as well as comprehensive coverage of business-essential preparatory topics, including market overview analysis, competitive landscape, commercial segmentation, regulatory pathways, product positioning, cross-border business partnership and key IP considerations.
Chenchen Liu, Manager of Business Advisory Services at Dezan Shira & Associates’ Shanghai office, will participate in the webinar to share her expertise on IP protection strategies and practices in China.
Date & Time
- Tuesday, January 21st 2025, 16:00 (PST)/17:00 (MST)/18:00 (CST)/19:00 (EST)/20:00 (AST)/21:00 (NST)
- Wednesday, January 22nd 2025, 8:00 (Beijing Time)
Key Topics
- China IVD Market Overview
- Real-world Cross-border Business Partnership Model
- Marketing Strategy and Best Practices in China IVD Market
- NMPA Regulatory Requirements & Registration Pathway
- IP Protection Strategy & Practices in China
Speakers
- Samuel Boateng: Consul and Trade Commissioner, Consulate General of Canada in Shanghai
- Stephanie Chen: Market Research Director, SAI MedPartners
- Byron Luo: General Manager, Business Development, CoWin BioSciences
- Karen Dai: Executive General Secretary, China Association of In Vitro Diagnostics
- Grace Fu Palma: Principal, China Med Device, Accel Groups
- Chenchen Liu: Manager of Business Advisory, Dezan Shira & Associates
Our Clients
Discover our esteemed global clients across diverse sectors. We believe in providing our clients with exceptional service and a commitment to being their partner for growth in Asia.
See what our clients say about us